NCT06398444 2025-09-05A Clinical Study of Lutetium[177Lu] Oxodotreotide Injection in Patients With Advanced Neuroendocrine NeoplasmsSinotau Pharmaceutical GroupPhase 2/3 Active not recruiting74 enrolled